INS and metabolic syndrome: The reviewed studies indicate that these risk factors typical of metabolic syndrome are linked with the disturbed hepatic ER function affecting the fate of lipids, proteins, glucose and insulin.The studies also show that gene-activating therapy can eliminate abnormalities in the syndrome.